SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Sernova Biotherapeutics Announces Warrant Amendments
February 20, 2026
 · 
3 min read
Press Releases
Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
This Press Release identifies that Dr. Kulkarni has participated in a medical advisory position for Theralase(R) in the past.
February 20, 2026
 · 
8 min read
Press Releases
From AI-driven drug discovery to the era of “cell debugging.” - Commentary by Unexakorea
February 20, 2026
 · 
1 min read
Press Releases
Organic Longevity Biotechnology: A New Paradigm for Anti-Aging, Lifespan Extension, and Rejuvenation
February 20, 2026
 · 
1 min read
Press Releases
MDCE CEO Expands Open-Market Position to 66,199,283 Shares After Previously Returning Nearly 2 Billion Shares to Treasury
February 20, 2026
 · 
3 min read
Press Releases
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
February 20, 2026
 · 
1 min read
Press Releases
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
February 20, 2026
 · 
1 min read
Press Releases
ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients
February 20, 2026
 · 
10 min read
Press Releases
enGene to Participate in Upcoming Investor Conferences - February 20, 2026
February 20, 2026
 · 
1 min read
Press Releases
Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference
February 20, 2026
 · 
1 min read
Press Releases
CORRECTION FROM SOURCE: The Nomination Committee’s Proposal for New Board Members
February 20, 2026
 · 
2 min read
Press Releases
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
February 20, 2026
 · 
6 min read
Press Releases
Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial
February 20, 2026
 · 
4 min read
Press Releases
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference
February 20, 2026
 · 
4 min read
Press Releases
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
February 20, 2026
 · 
4 min read
Press Releases
Annual General Meeting in ALK-Abelló A/S on 16 March 2026
February 20, 2026
 · 
1 min read
Press Releases
Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy Trial
February 20, 2026
 · 
10 min read
Press Releases
The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors
February 20, 2026
 · 
2 min read
Press Releases
ABLi Therapeutics Announces Publication of the Final Results from the Phase 2 ‘201 Trial’ Evaluating Risvodetinib for the Treatment of Parkinson’s Disease
February 20, 2026
 · 
3 min read
Press Releases
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference
February 20, 2026
 · 
5 min read
Press Releases
AltruBio Announces Formation of Inflammatory Bowel Disease Clinical Advisory Board
February 20, 2026
 · 
7 min read
Press Releases
Nasus Pharma to Participate in Upcoming Investor Conferences - February 20, 2026
February 20, 2026
 · 
1 min read
Press Releases
Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements
February 20, 2026
 · 
5 min read
Press Releases
Telix to Participate in Oppenheimer and TD Cowen Conferences
February 20, 2026
 · 
5 min read
Press Releases
Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
February 12, 2026
 · 
1 min read
Press Releases
Zelluna ASA: Fourth Quarter 2025 – Key regulatory milestone achieved with CTA Submission
February 12, 2026
 · 
2 min read
Press Releases
NMD Pharma results from Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2 selected for late-breaking oral presentation at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
February 12, 2026
 · 
5 min read
Press Releases
Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance
February 12, 2026
 · 
15 min read
Press Releases
WuXi Vaccines Receives Brazil’s ANVISA GMP Certification
February 12, 2026
 · 
2 min read
Press Releases
Nektar Therapeutics Announces Pricing of Upsized $400 Million Public Offering
February 12, 2026
 · 
6 min read
Press Releases
BioRestorative Announces Pricing of $5.0 Million Public Offering
February 12, 2026
 · 
5 min read
Press Releases
Xilio Therapeutics Announces Pricing of Underwritten Offering
February 12, 2026
 · 
4 min read
Press Releases
U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
February 12, 2026
 · 
13 min read
Press Releases
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 11, 2026
February 12, 2026
 · 
1 min read
Load More